In non-small cell lung cancer (NSCLC), lactylation at H3K18 activates the POM121/MYC/PD-L1 axis, leading to diminished CD8+ T-cell activity and enhanced immune evasion [100]. Here, CD8A is linked to non-small cell lung carcinoma.